China Pharma Holdings (CPHI) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $37.3 million.
- China Pharma Holdings' Other Gross PP&E Adjustments fell 154.11% to $37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year decrease of 154.11%. This contributed to the annual value of $36.9 million for FY2024, which is 116.38% down from last year.
- Latest data reveals that China Pharma Holdings reported Other Gross PP&E Adjustments of $37.3 million as of Q3 2025, which was down 154.11% from $37.2 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Other Gross PP&E Adjustments ranged from a high of $37.9 million in Q3 2024 and a low of -$25369.0 during Q1 2021
- In the last 5 years, China Pharma Holdings' Other Gross PP&E Adjustments had a median value of $28.5 million in 2022 and averaged $19.4 million.
- In the last 5 years, China Pharma Holdings' Other Gross PP&E Adjustments tumbled by 10537.22% in 2021 and then soared by 697833.98% in 2024.
- Quarter analysis of 5 years shows China Pharma Holdings' Other Gross PP&E Adjustments stood at $488309.0 in 2021, then surged by 5733.46% to $28.5 million in 2022, then skyrocketed by 31.21% to $37.4 million in 2023, then decreased by 1.16% to $36.9 million in 2024, then rose by 0.91% to $37.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at $37.3 million for Q3 2025, versus $37.2 million for Q2 2025 and $37.1 million for Q1 2025.